-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Teva Pharmaceutical Industries Ltd quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2010 to Q3 2024.
- Teva Pharmaceutical Industries Ltd Net Cash Provided by (Used in) Operating Activities for the quarter ending September 30, 2024 was $693M, a 13760% increase year-over-year.
- Teva Pharmaceutical Industries Ltd Net Cash Provided by (Used in) Operating Activities for the twelve months ending September 30, 2024 was $1.86B, a 60.4% increase year-over-year.
- Teva Pharmaceutical Industries Ltd annual Net Cash Provided by (Used in) Operating Activities for 2023 was $1.37B, a 14% decline from 2022.
- Teva Pharmaceutical Industries Ltd annual Net Cash Provided by (Used in) Operating Activities for 2022 was $1.59B, a 99.2% increase from 2021.
- Teva Pharmaceutical Industries Ltd annual Net Cash Provided by (Used in) Operating Activities for 2021 was $798M, a 34.4% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)